Log in to save to my catalogue

Vasopressin in neonatal hypertrophic cardiomyopathy: do perceived benefits translate to clinical out...

Vasopressin in neonatal hypertrophic cardiomyopathy: do perceived benefits translate to clinical out...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2491947943

Vasopressin in neonatal hypertrophic cardiomyopathy: do perceived benefits translate to clinical outcome?

About this item

Full title

Vasopressin in neonatal hypertrophic cardiomyopathy: do perceived benefits translate to clinical outcome?

Publisher

New York: Nature Publishing Group US

Journal title

Journal of perinatology, 2021-04, Vol.41 (4), p.905-906

Language

English

Formats

Publication information

Publisher

New York: Nature Publishing Group US

More information

Alternative Titles

Full title

Vasopressin in neonatal hypertrophic cardiomyopathy: do perceived benefits translate to clinical outcome?

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2491947943

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2491947943

Other Identifiers

ISSN

0743-8346

E-ISSN

1476-5543

DOI

10.1038/s41372-021-00937-7

How to access this item